A recent milestone study used the LNP delivery system developed by Acuitas Therapeutics to treat a newborn with urea cycle ...

Gene therapy offers the possibility of addressing cancer at its molecular roots by targeting disease-causing genes rather than relying solely on ...

Navratri season is here, and with it comes the energy of Garba and Dandiya nights. While smartphones capture festive moments, AI tools like Google Gemini, ChatGPT, and other creative image-generation ...

Norwegian design brand Volver worked with designer Kristine Five Melvær on a range of kaleidoscopic hand tufted rugs ...

FIG slides as slowing growth, stiff competition, and margin pressure weigh against its expanding AI-powered product lineup.

Epicrispr Biotechnologies CEO Amber Salzman, Ph.D. offers up four imperatives for industry leaders working to develop ...

Rocket Pharmaceuticals, Inc. ( NASDAQ: RCKT) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 9:15 AM EDT ...

With CDMOs playing such a prominent role in biomanufacturing, GEN asked several CDMO leaders for their take on the top trends in the industry, the main challenges facing CDMOs today, and the most ...

To this session of the Morgan Stanley Global Healthcare Conference. I'm excited to welcome the team from 4D Molecular Therapeutics. Let me just get through a quick disclosure before we get started.

Detailed price information for Molecular Partners Ag ADR (MOLN-Q) from The Globe and Mail including charting and trades.

The study by Reed et al. provides fundamental findings and convincing evidence defining the topological changes that occur during tumorigenesis. The findings enhance the understanding of stable ...